Sort by
Refine Your Search
-
Department has six sections, including the Section of Molecular Microbiology which will host the new appointment. The Section is a key constituent of Centre for Bacterial Resistance Biology (CBRB) and
-
analysis) at a world-leading institution and be part of a multidisciplinary team of Researchers from Academia and Industry. An opportunity to work with a team of highly enthusiastic scientists pursuing
-
of synthetic strategies, including analysis and purification Ability to supervise students from a wide range of backgrounds in synthetic chemistry/drug discovery. Desirable experience for this role includes one
-
-protein interaction) and analysis Experience in target validation and/or chemical inhibitor testing using in vitro models, i.e., cell lines Strong research track record relative to experience, in academia
-
journal impact factor where it is published. For more information, see https://www.imperial.ac.uk/research-and-innovation/about-imperial-research/research-evaluation/ The College believes that the use
-
, including advising on preparing the financial elements of grant applications and management of grants/contracts awarded. Including regularly reviewing expenditure and advising project leads of problems
-
, or quality improvement initiatives within a service environment. Significant experience using case management systems, with strong skills in data management, reporting, and analysis. A dynamic working
-
Declaration on Research Assessment (DORA), which means that in hiring and promotion decisions, we evaluate applicants on the quality of their work, not the journal impact factor where it is published. For more
-
estate-specific needs are translated into enterprise solutions. You will drive performance through reporting and data analysis, advising the Leadership Team on management decisions through data insights
-
capabilities/technologies/IP portfolio Assessment of research discoveries, analysis and evaluation, and advancement of those technologies through collaboration with industry, access to translational funds, and